Nabil Khalid Thalji, MD, PhD

faculty photo
Assistant Professor of Anesthesiology and Critical Care
Department: Anesthesiology and Critical Care

Contact information
Hospital of the University of Pennsylvania
Department of Anesthesiology and Critical Care
3400 Spruce Street, Dulles 6
Philadelphia, PA 19104
Education:
BS (Biochemistry)
Louisiana State University, 2009.
BS (Chemistry)
Louisiana State University, 2009.
PhD (Pharmacology)
Perelman School of Medicine at the University of Pennsylvania, 2015.
MD
Perelman School of Medicine at the University of Pennsylvania, 2017.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Thalji NK, Patel SJ, Augoustides JG, Schiller RJ, Dalia AA, Low Y, Hamzi RI, Fernando RJ: Opioid-Free Cardiac Surgery: A Multimodal Pain Management Strategy With a Focus on Bilateral Erector Spinae Plane Block Catheters Journal of Cardiothoracic and Vascular Anesthesia 36(12): 4523-4533, December 2022 Notes: doi: 10.1053/j.jvca.2022.09.002. Epub 2022 Sep 8.

Thalji NK, Patel PA : Out of Control: Why Randomized Trials of Factor Concentrates are So Elusive. Journal of Cardiothoracic and Vascular Anesthesia 35(9): 2659-2661, September 2021 Notes: doi: 10.1053/j.jvca.2021.06.011. Epub 2021 Jun 12.

Thalji NK, Chabata CV, Patel PA, Sullenger BA, Camire RM : Characterization of Andexanet Alfa-Associated Heparin Resistance: Implications for Management XXIXth Congress of the International Society on Thrombosis and Haemostasis, Philadelphia, PA July 2021 Notes: (Poster Presentation).

Thalji NK, Patel PA, Elliot M, Augoustides JG : Hematologic Consequences of the Coronavirus Crisis-Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community. Journal of Cardiothoracic and Vascular Anesthesia 34(12): 3189-3192, September 2020 Notes: doi: 10.1053/j.jvca.2020.05.032. Epub 2020 May 27.

Thalji NK, Patel PA, Camire RM: Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass. 61st Annual Meeting of the American Society of Hematology, Orlando, FL December 2019 Notes: (Poster Presentation).

Gunaratne R, Kumar S, Frederiksen JW, Stayrook S, Lohrmann JL, Perry K, Bompiani KM, Chabata CV, Thalji NK, Ho MD, Arepally G, Camire RM, Krishnaswamy S, Sullenger BA: Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass. Nature Biotechnology 36(7): 606-613, August 2018 Notes: doi: 10.1038/nbt.4153. Epub 2018 Jun 4.

Thalji NK, Camire RM : Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding. Current Opinions in Hematology 24(5): 453-459, September 2017 Notes: DOI: 10.1097/moh.0000000000000369 PMID: 28692575 PMCID: PMC5629015.

Thalji NK, Ivanciu L, Davidson R, Gimotty PA, Krishnaswamy S, Camire RM : A rapid pro-hemostatic approach to overcome direct oral anticoagulants. Nature Medicine 22(8): 924-32, August 2016 Notes: doi: 10.1038/nm.4149. Epub 2016 Jul 25.

George LA, Thalji NK, Cronin MN, Raffini LJ, Gimotty PA, Camire RM: Correction of Human Hemophilia A Whole Blood Abnormalities with a Novel Bypass Agent: Zymogen- Like FXaI16L. Journal of Thrombosis and Haemostasis 13(9): 1694-1698, September 2015 Notes: DOI:https://doi.org/10.1111/jth.13059.

Thalji N, Camire RM: Parahemophilia: New Insights into Factor V deficiency. Seminars in Thrombosis and Hemostasis 39(6): 607-612, September 2013 Notes: doi: 10.1055/s-0033-1349224. Epub 2013 Jul 26.

back to top
Last updated: 04/19/2024
The Trustees of the University of Pennsylvania